DHR vs MAR: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Marriott International, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Marriott International, Inc. · Consumer Cyclical
$334.97
+20.6% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MAR |
| Current Price |
$221.12 |
$334.97 |
| Fair Value Estimate |
$286.52 |
$403.81 |
| Upside to Fair Value |
+29.6%
|
+20.6%
|
| Market Cap |
$155.4B |
$87.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
22.2x
|
| Price / Sales |
6.2x
|
3.2x
|
| Price / FCF |
28.5x
|
28.7x
|
| Revenue Growth YoY |
+5.5%
|
+4.8%
|
| Gross Margin |
58.5%
|
20.2%
|
| Operating Margin |
20.4%
|
15.8%
|
| Return on Equity |
7.7%
|
-66.7%
|
| Dividend Yield |
0.65% |
0.84% |
| FCF Yield |
3.51%
|
3.48%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Marriott International is a global asset-light hotel franchisor and manager whose 10,082-property, 1.814 million-room system, 629,000-room development pipeline, broad brands, and more than 295 million Bonvoy members support durable fee-led economics. Business quality is tempered by cyclicality, competitive owner incentives, and $16.915 billion of debt, while reported ROE is negative 66.7%. In the…
Accumulation Zones
| Metric |
DHR |
MAR |
| Zone Low |
$214.89 |
$302.86 |
| Zone High |
$243.54 |
$343.24 |
| In Buy Zone? |
Yes
|
Yes
|